Adverse Event Reporting
VAERS ID | 2243087 |
---|---|
Gender | Male |
Age | |
StateCode | |
Pharmaceutical Company | PFIZER\BIONTECH |
Lot Number | |
Number of vaccinations | |
Vaccinated | 2022-03-01 |
Onset | 2022-03-01 |
Condition | Hospitalized |
Symptoms
- Chest pain
- Electrocardiogram
- Magnetic resonance imaging
- Troponin
- Echocardiogram
- Myocarditis
Current Illness
Preexisting Conditions
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Test Name: Echo; Result Unstructured Data: Test Result:Abnormal; Test Name: EKG; Result Unstructured Data: Test Result:Abnormal; Test Name: MRI; Result Unstructured Data: Test Result:Post event scarring on MRI; Test Name: Tropinon; Result Unstructured Data: Test Result:High Tropinon
Write-up
myocarditis; chest pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).
The reporter is the parent.
A male patient received BNT162b2 (BNT162B2), in Mar2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation.
The patient's relevant medical history and concomitant medications were not reported.
Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 immunization.
The following information was reported: MYOCARDITIS (hospitalization, medically significant) with onset Mar2022, outcome "unknown"; CHEST PAIN (non-serious), outcome "unknown".
The patient underwent the following laboratory tests and procedures: Echocardiogram: Abnormal; Electrocardiogram: Abnormal; Magnetic resonance imaging: Post event scarring on MRI; Troponin: High Tropinon.
Clinical Course: A potential AE has been reported to the Contact Center.
Reporter reported for their son that he was hospitalized and has been waiting patiently March, 2.
5 days after the booster for myocarditis.
The booster was a Pfizer Product.
Lot Number was not provided.
Any other additional information was not provided The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.